about
Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugsInduced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissuesMesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissuesDevelopmental stage-dependent effects of cardiac fibroblasts on function of stem cell-derived engineered cardiac tissues.Characterization of H type 1 and type 1 N-acetyllactosamine glycan epitopes on ovarian cancer specifically recognized by the anti-glycan monoclonal antibody mAb-A4.Characterizing Protein Glycosylation through On-Chip Glycan Modification and ProbingCharacterizing functional stem cell-cardiomyocyte interactions.Shotgun Glycomics Identifies Tumor-Associated Glycan Ligands Bound by an Ovarian Carcinoma-Specific Monoclonal Antibody.
P50
Q26773052-CD0A6F2B-2D2A-43A3-9063-68DFF48D4F8AQ27315974-98CE3D5D-2EEF-44E0-975C-D4D626D8049AQ30496172-B7599090-BC94-4388-86FD-401ABBC33090Q30838004-45320FDC-19DC-4867-92E1-F619F754C058Q33564920-76017A26-8109-4DB9-BA9F-A0936AD34348Q37623120-1F790C63-8A42-45C9-B16F-06E106AA050BQ37657548-7C81FA02-092A-4296-8D77-EE4468E1AB82Q47125093-969DC61E-0F0D-47F9-AC3D-933EA99B57DE
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8233-771X
@en
name
Brian Liau
@ast
Brian Liau
@en
Brian Liau
@es
Brian Liau
@nl
type
label
Brian Liau
@ast
Brian Liau
@en
Brian Liau
@es
Brian Liau
@nl
prefLabel
Brian Liau
@ast
Brian Liau
@en
Brian Liau
@es
Brian Liau
@nl
P106
P1153
36910002700
P31
P496
0000-0002-8233-771X